Flow-mediated dilatation (FMD), which is dependent upon endothelial release of NO and is considered a surrogate marker of atherosclerosis [29], has been evaluated in patients with NOX2 (X-linked CGD) [30] or p47phox hereditary deficiency. This evidence concerns the gene CYBB and hyperinsulinemic hypoglycemia, familial, 4.